The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...

Conductor Daniel Barenboim says he has been diagnosed with Parkinson’s disease. The 82-year-old issued a statement Thursday ...

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's ...

Ozzy Osbourne is struggling to walk amid his battle with Parkinson’s disease — but his singing voice is “as good as ever,” ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease ...

Ozzy Osbourne shares a heartbreaking update on his Sirius XM radio show about his Parkinson's diagnosis. The rocker tells his fans, 'I can’t walk, but you know what I was thinking over the holidays?

What is Ozzy Osbourne's health situation? Ozzy lives with Parkinson's disease, and has had numerous surgeries over the ...